| Literature DB >> 28656141 |
Andreas Wittke1, Simon von Stengel1, Michael Hettchen1, Michael Fröhlich2, Jürgen Giessing3, Michael Lell4, Michael Scharf5, Michael Bebenek1, Matthias Kohl6, Wolfgang Kemmler1.
Abstract
High intensity (resistance exercise) training (HIT) defined as a "single set resistance exercise to muscular failure" is an efficient exercise method that allows people with low time budgets to realize an adequate training stimulus. Although there is an ongoing discussion, recent meta-analysis suggests the significant superiority of multiple set (MST) methods for body composition and strength parameters. The aim of this study is to determine whether additional protein supplementation may increase the effect of a HIT-protocol on body composition and strength to an equal MST-level. One hundred and twenty untrained males 30-50 years old were randomly allocated to three groups: (a) HIT, (b) HIT and protein supplementation (HIT&P), and (c) waiting-control (CG) and (after cross-over) high volume/high-intensity-training (HVHIT). HIT was defined as "single set to failure protocol" while HVHIT consistently applied two equal sets. Protein supplementation provided an overall intake of 1.5-1.7 g/kg/d/body mass. Primary study endpoint was lean body mass (LBM). LBM significantly improved in all exercise groups (p ≤ 0.043); however only HIT&P and HVHIT differ significantly from control (p ≤ 0.002). HIT diverges significantly from HIT&P (p = 0.017) and nonsignificantly from HVHIT (p = 0.059), while no differences were observed for HIT&P versus HVHIT (p = 0.691). In conclusion, moderate to high protein supplementation significantly increases the effects of a HIT-protocol on LBM in middle-aged untrained males.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28656141 PMCID: PMC5471590 DOI: 10.1155/2017/3619398
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Flow-chart of the PUSH study.
Figure 2Study design of the PUSH study.
Baseline characteristics of the PUSH study groups.
| Variables | HIT | HIT&P | HVHIT | Control |
|
|---|---|---|---|---|---|
| Age [y] | 42.9 ± 5.4 | 43.7 ± 5.9 | 42.9 ± 5.6 | 42.5 ± 5.6 | 0.717/.451 |
| Body Mass Index | 27.5 ± 4.0 | 27.3 ± 4.1 | 26.9 ± 4.2 | 26.8 ± 4.3 | 0.376/.770 |
| Total body fat mass [kg] | 25.6 ± 5.1 | 25.0 ± 4.8 | 24.9 ± 6.1 | 24.9 ± 6.0 | 0.904/.172 |
| Physical activity [index]1 | 2.9 ± 1.4 | 2.8 ± 1.3 | 2.7 ± 1.2 | 2.7 ± 1.1 | 0.818/.311 |
| Exercise volume [min/week] | 28.4 ± 35.9 | 40.1 ± 41.8 | 35.0 ± 37.9 | 35.0 ± 38.2 | 0.640/.564 |
| Working time [h/week] | 43.4 ± 3.2 | 44.5 ± 2.9 | 43.5 ± 3.1 | 44.1 ± 3.5 | 0.322/1.17 |
| Upper/middle/lower class [%] | 20/68/12 | 25/63/12 | 18/73/9 | 18/73/9 | ≥0.816/.942 |
| University studies [%] | 70 | 78 | 75 | 75 | 0.785/1.072 |
| Smokers [ | 1 | 1 | 2 | 2 | 0.733/3.592 |
| Diseases (ICD-10) [%] | 20 | 25 | 22 | 21 | 0.963/.292 |
| Chronic medication [%] | 10 | 13 | 13 | 13 | 0.981/.182 |
| Energy intake [kcal/day]3 | 2658 ± 723 | 2703 ± 662 | 2559 ± 592 | 2516 ± 758 | 0.671/.518 |
| Protein intake [g/kg/d]3 | 1.13 ± 0.29 | 1.21 ± 0.39 | 1.17 ± 0.40 | 1.12 ± 0.34 | 0.294/1.25 |
| Fat/CHO/alcohol [g/d]3 | 99/305/12 | 106/314/12 | 100/286/14 | 94/298/14 | ≥0.20/.199 |
1Based on a scale from 1 (very low) to 7 (very high) according to a subjective assessment of professional, household, and recreational activities. 2Chi square test value; 3based on a 4-day dietary intake protocol. CHO: carbohydrates.
Exercise protocol. TUT: time under tension; exs: exercises; reps: repetitions; RegW: regeneration week; SuS: superset; expl: explosive (very fast) movement velocity.
| Time | Number of reps (break) | Work to failure strategy | TUT (s) |
|---|---|---|---|
| Phase 1 | |||
| Weeks 1-2 | Familiarization phase | Incomplete work to failure | 2-1-2 |
| Weeks 3–6 | Conditioning phase: | Incomplete work to failure | 2-1-2 |
|
| |||
| Phase 2 | 8–10 reps (break 2-3 min) | MMF | expl-1-2 |
| Weeks 7–10 | 5–7 reps (break 2 min) | MMF | 2-1-2 |
| 3–5 reps (break 60 s) | MMF | 4-1-2 | |
| RegW: 10–12 reps (break 2 min) | MMF -3 reps | 2-1-2 | |
|
| |||
| Phase 3 | See phase 2, however, break | See phase 2 + supersets | expl-1-2 |
| Weeks 11–14 | between SuS-exercises: 60 s; between SuS | (1) Session/week agonists SuS1 | to |
| “blocks” 2 min | (2) Session/w. antagonists SuS2 | 4-1-4 | |
| Week 4: RegW (see phase 2) | 2–4 exercises per SuS “block” | 2-1-2 | |
|
| |||
| Phase 4 | See phase 3 | See phase 3 and drop-set with a single load reduction of −10–15% for each exercise immediately after work to MMF | 3-1-3 |
| Weeks 13–18 | 2 min breaks | ||
| Week 4: RegW | |||
|
| |||
| Phase 5 | See | See phase 3 and drop-sets with a twofold reduction of −10 and −10% for each exercise immediately after work to MMF and MMF+ | 3-1-3 |
| Weeks 19–22 | phase 3 | ||
| Week 4: RegW | |||
Baseline values and changes of LBM in the study groups. p < 0.05; p < 0.001; n.s.: nonsignificant.
| LBM [kg] | HIT | HIT&P | HVHIT | CG |
|
|---|---|---|---|---|---|
| Baseline | 67.2 (64.8–69.6) | 67.8 (65.1–70.4) | 65.7 (63.2–68.2) | 65.6 (64.1–68.1) | 0.53 |
| Difference | 0.45 (.15–.85) | 1.38 (.95–1.81) | 1.24 (.76–1.73) | 0.04 (−.38–.45)n.s. | 0.001 |
Baseline values and changes of ASMM, isokinetic leg and hip extensor strength, and total body fat-rate in the study groups.p < 0.05; p < 0.01; p < 0.001; n.s.: nonsignificant.
| HIT | HIT&P | HVHIT | CG |
| |
|---|---|---|---|---|---|
|
| |||||
| Baseline | 31.24 (30.0–32.4) | 31.22 (29.9–32.6) | 30.19 (28.9–31.5) | 30.17 (29.0–31.4) | 0.44 |
| Difference | 200 (−29–429)n.s. | 797 (557–1037) | 581 (299–862) | 15 (−219–249)n.s. | 0.001 |
|
| |||||
|
| |||||
| Baseline | 3239 (3027–3481) | 3323 (3145–3501) | 3315 (3153–3519) | 3288 (3101–3475) | 0.61 |
| Difference | 446 (253–637) | 418 (279–555) | 334 (239–429) | 27 (−56–111)n.s. | 0.001 |
|
| |||||
|
| |||||
| Baseline | 25.61 (24.0–27.3) | 25.00 (23.5–26.6) | 24.97 (22.7–26.9) | 24.9 (23.1–27.1) | 0.51 |
| Difference | −1.20 (−.75–1.67) | −.44 (.05–.90)n.s. | −.86 (−.31–1.40) | 0.06 (.50–.39)n.s. | 0.001 |